What is the presence of reflux in the Common Femoral Vein (CFV), Great Saphenous Vein (GSV), Superficial Femoral Vein (SFV), Popliteal Vein, Anterior Tibial Vein (ATV), and Posterior Tibial Vein (PTV)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The most appropriate treatment for varicose veins, based on recent evidence, is endovenous thermal ablation, which has been shown to be effective for larger vessels, including the greater saphenous vein 1. The provided form appears to be a venous ultrasound assessment form for evaluating the patency of leg veins, which is a crucial diagnostic tool for identifying varicose veins and guiding treatment decisions. Some key points to consider when evaluating varicose veins include:

  • The presence or absence of deep venous insufficiency and the characteristics of the affected veins can help guide treatment 1.
  • Compression stockings can provide relief from discomfort, although evidence is lacking, and external compression is first-line treatment only in pregnant women 1.
  • Lifestyle modifications, such as avoidance of prolonged standing and straining, exercise, wearing nonrestrictive clothing, modification of cardiovascular risk factors, and interventions to reduce peripheral edema, can also be beneficial 1.
  • Weight loss may improve symptoms in patients who are obese 1.
  • Phlebotonics, such as horse chestnut seed extract, may provide symptomatic relief, but long-term studies are lacking 1.
  • Interventional treatments, such as thermal ablation, endovenous sclerotherapy, and surgery, may be necessary for more severe cases 1. It is essential to note that the decision to proceed with treatment and the choice of treatment are based on symptoms and patient preferences, as well as other considerations, including cost, potential for complications, availability of resources, insurance reimbursement, and physician training 1.

From the Research

CFV/GSV and SFV Proximal

  • The provided data shows a series of "YES" and "NO" responses for CFV/GSV and SFV proximal, but without context, it's difficult to determine the relevance to the studies provided 2, 3, 4, 5, 6.
  • The studies focus on the treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE), with discussions on the use of rivaroxaban, enoxaparin, and other anticoagulants.

SFV Mid and Distal

  • Similar to the SFV proximal, the data for SFV mid and distal shows "YES" and "NO" responses, but lacks context for direct correlation with the provided studies.
  • Studies like 3 and 6 discuss the efficacy and safety of various anticoagulants in preventing VTE, which could be relevant to understanding the importance of monitoring and treating DVT in different parts of the leg.

Popliteal, ATV, and PTV Distal

  • The "YES" and "NO" responses for these categories also lack direct context to the studies provided.
  • However, the general topic of DVT and its treatment is relevant, as studies 2, 3, and 5 highlight the importance of early diagnosis and appropriate treatment to prevent complications like pulmonary embolism.

Relevance of Studies

  • While the studies provided offer insights into the treatment and prevention of DVT and PE, they do not directly address the specific "YES" and "NO" responses given for the various categories.
  • Studies 4 and 5 emphasize the importance of nursing assessment and patient evaluation in the context of DVT, which might indirectly relate to the categorizations provided, assuming they pertain to patient assessment or treatment outcomes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Enoxaparin Treatment Followed by Rivaroxaban for the Treatment of Acute Lower Limb Venous Thromboembolism: Initial Experience in a Single Center.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2016

Research

Nursing assessment of deep vein thrombosis.

Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses, 2013

Research

Understanding patient assessment and treatment in deep vein thrombosis.

Nursing standard (Royal College of Nursing (Great Britain) : 1987), 2022

Related Questions

What is the presence of reflux in the Common Femoral Vein (CFV), Great Saphenous Vein (GSV), Superficial Femoral Vein (SFV), Popliteal Vein, Anterior Tibial Vein (ATV), and Posterior Tibial Vein (PTV)?
What is the preferred choice between Clexane (enoxaparin) and Rivaroxaban for the prevention of deep vein thrombosis (DVT) in hospitalized patients?
What is the workup for bilateral leg swelling in an elderly male after hip surgery with normal Venous Duplex (venous ultrasound) and unresponsive to Lasix (furosemide)?
What is the recommended duration of Xarelto (rivaroxaban) therapy for a 61-year-old female with deep vein thrombosis (DVT) in the knee following surgery?
What is the cause of bilateral leg edema in a 75-year-old male with a history of deep vein thrombosis (DVT) in 2017, currently on Xarelto (rivaroxaban), without heart failure or kidney disease?
What is the common dosing schedule for using hypertonic saline in combination with a loop diuretic, such as Furosemide (Lasix), for refractory heart failure?
What is the use of Ozempic (semaglutide)?
What is the presence of reflux in the Common Femoral Vein (CFV), Great Saphenous Vein (GSV), Superficial Femoral Vein (SFV), Popliteal Vein, Anterior Tibial Vein (ATV), and Posterior Tibial Vein (PTV)?
Can Gardasil (Human Papillomavirus vaccine) reduce the incidence of actinic keratoses?
Is there reflux present in the Common Femoral Vein (CFV), Great Saphenous Vein (GSV), and other specified venous segments?
Is a Prostate-Specific Antigen (PSA) level increase from 1.9 to 2.97 ng/mL significant?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.